These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18553185)

  • 1. [Immunologic control parameters during specific immunotherapy].
    Ott H; Wosnitza M; Merk HF
    Hautarzt; 2008 Jul; 59(7):551-6. PubMed ID: 18553185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of specific immunotherapy].
    Bellinghausen I; Knop J; Saloga J
    Hautarzt; 2006 Oct; 57(10):855-9. PubMed ID: 16955304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current recommendations for the use of SCIT and SLIT].
    Lee H; Kleine-Tebbe J; Zuberbier T; Worm M
    Hautarzt; 2006 Oct; 57(10):860-6. PubMed ID: 16964477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-specific immunotherapy: an update on immunological mechanisms of action.
    Ciprandi G; Marseglia GL; Tosca MA
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mechanisms of allergen-specific immunotherapy.
    Jutel M; Akdis CA
    Allergy; 2011 Jun; 66(6):725-32. PubMed ID: 21466562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of sublingual immunotherapy with one or more allergens in adults.
    Lombardi C; Gargioni S; Cottini M; Canonica GW; Passalacqua G
    Allergy; 2008 Mar; 63(3):375-6. PubMed ID: 18269680
    [No Abstract]   [Full Text] [Related]  

  • 11. [Specific immunotherapy (SIT) in atopic dermatitis and food allergy].
    Niebuhr M; Kapp A; Werfel T
    Hautarzt; 2008 Jul; 59(7):544-50. PubMed ID: 18528671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications.
    Aryan Z; Compalati E; Canonica GW; Rezaei N
    Expert Rev Vaccines; 2013 Jun; 12(6):639-59. PubMed ID: 23750794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
    Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
    BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment.
    Wong PH; Quinn JM; Gomez RA; Webb CN
    J Allergy Clin Immunol Pract; 2017; 5(5):1438-1439.e1. PubMed ID: 28499782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular-allergological aspects of allergen-specific immunotherapy].
    Jappe U
    Hautarzt; 2017 Apr; 68(4):271-281. PubMed ID: 28293695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic reactions to allergen immunotherapy: a review of the literature.
    Nettis E; Giordano D; Ferrannini A; Tursi A
    Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):1-11. PubMed ID: 12675195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
    Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.
    Zidarn M; Košnik M; Šilar M; Bajrović N; Korošec P
    Allergy; 2015 May; 70(5):547-55. PubMed ID: 25627309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cluster immunotherapy in allergic rhinoconjunctivitis: review of a new therapeutic approach].
    Pfaar O; Klimek L
    Hautarzt; 2006 Oct; 57(10):875-80. PubMed ID: 16969674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.